An observational study in Covid19, sponsored by Universidad Autonoma de Madrid. Completed at 1 site in Spain. Open to participants aged 12 Years to 99 Years. Per ClinicalTrials.gov, last updated 2021-04-06.
Sponsored by Universidad Autonoma de Madrid · Observational
The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 114 is below the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →Universidad Autonoma de Madrid is the lead sponsor of 48 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects aged 18 to 90 years were recruited by non-probabilistic convenience sampling in Primary Health Care Centres of the Primary Health Care Management of SERMAS and the Intensive Care Unit of the University Hospital of Gran Canaria Doctor Negrín of the Canary Health Service
Inclusion Criteria:
Patients diagnosed with Covid19 positive in last 7 days
Diagnostic Test: Roth´s Test
Subjets must count from 1 to 30 in their languages, and health professional will count seconds that last in take breath during the count.
Oxygen Saturation
The pulseoximeter percentage value
Time frame: 12 weeks
Roth´s test
The level described in the test
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Autonoma de Madrid